Skip to main content
. 2024 Jun 25;24:729. doi: 10.1186/s12903-024-04510-4

Table 2.

Correlations between LMO7 expression and staining intensity and clinicopathologic characteristics

Variable LMO7 expression
0–50%
n (%)
51–100%
n (%)
P value
Sex Male 37 (47) 42 (53) 0.285b
Female 11 (65) 6 (35)
Stage TNM 8 I 1 (17) 5 (83) 0.177c
II 28 (51) 27 (49)
III 14 (64) 8 (36)
IV 5 (38) 8 (62)
Localization Tonsil 33 (53) 29 (47) 0.492c
Base of tongue 10 (40) 15 (60)
Other oropharyngeal 5 (56) 4 (44)
Differentiation grade Low 14 (37) 24 (63) 0.036c*
Moderate 30 (62) 18 (38)
High 3 (33) 6 (67)
NK 1 0
Smoking habit Smoker 31 (56) 24 (44) 0.097b
Nonsmoker 13 (38) 21 (62)
Unknown 4 3
Recurrence Yes 13 (65) 7 (35) 0.31b
No 30 (45) 36 (55)
Residual tumor 5 (50) 5 (50)
Vital status Alive 23 (40) 34 (60) 0.022b*
Dead 25 (64) 14 (36)
Cause of death Cancer 18 (62) 11 (38) 0.498b
Other 6 (75) 2 (25)
Unknown 1 1
LRIG1 expression Absent 0 1 (100) 0.048c*
1–25% 0 0
26–50% 1 (50) 1 (50)
51–75% 5 (100) 0
76–100% 40 (47) 45 (53)
NK 2 1
LRIG1 intensity No 0 1 (100) 0.744c
Weak 3 (75) 1 (25)
Intermediate 37 (49) 38 (51)
Strong 8 (53) 7 (47)
NK - 1
LMO7 intensity No 2 (100) 0 0.05c
Weak 12 (75) 4 (25)
Intermediate 21 (42) 29 (58)
Strong 4 (44) 5 (56)
NK 9 10
CD44 expression Absent 7 (70) 3 (30) 0.275b
1–25% 13 (45) 16 (55)
26–50% 4 (31) 9 (69)
51–75% 12 (63) 7 (37)
76–100% 11 (48) 12 (52)
NK 1 1
CD44 intensity No 7 (70) 3 (30) 0.347b
Weak 13 (45) 16 (55)
Intermediate 16 (43) 21 (57)
Strong 11 (61) 7 (39)
NK 1 1
Ki67 expression < Mean 33 (57) 25 (43) 0.093b
Mean 14 (38) 23 (62)
P53 expression Wild-type 37 (48) 40 (52) 0.442b
Mutated 11 (58) 8 (42)

LMO7 LIM domain 7 protein, NK not known, LRIG leucine-rich repeats and immunoglobulin-like domain

aIndependent samples t-test

bChi2-test

cFisher’s exact test

* = P < 0.05